A Phase 1 Trial Investigating LY4101174, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants with Recurrent, Advanced or Metastatic Solid Tumors

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-509867-26-00

Acronym

LOXO-ENC-23001

Enrollment

126

Registered

2024-05-22

Start date

2024-10-14

Completion date

Unknown

Last updated

2025-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced/metastatic solid tumor

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026